NSE:CIPLA - Cipla Limited Stock Price & Analysis

About Cipla Limited (NSE:CIPLA)

(NSE:CIPLA) Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. It also provides respiratory products, including inhalers and nasal sprays, as well as other dosage forms consists of injectables and biosimilars. Cipla Limited has collaboration with CSIR-Indian Institute of Chemical Technology for the development of medication for the treatment of COVID-19; and partnership with Karwa Ltd. for the commercialization of antibody detection kits for COVID-19, as well as the Premier Medical Corporation Private Limited for the commercialization of the rapid antigen test kits for COVID-19. The company was founded in 1935 and is headquartered in Mumbai, India.

CIPLA Stock Price

Statistics Highlights (NSE:CIPLA)

Shares Outstanding	806.81M	Beta	0.41
Public Float	532.08M	P/E Ratio	31.87
% Short of Float	-	Dividend (Yield)	-
Held by Insiders	38.09%	Ex-Dividend Date	Aug 9, 2021
Held by Institutions	32.57%	IPO Date	-

Explore More on "Statistics" Section

CIPLA Financial Summary

|

	Mar 21	Mar 20	Mar 19
Revenue	INR190.23B	INR168.26B	INR161.56B
EBITDA	INR45.14B	INR35.42B	INR35.87B
Net Income	INR24.05B	INR15.47B	INR15.28B
Total Assets	INR251.52B	INR236.63B	INR239.63B
Total Cash	INR7.93B	INR7.42B	INR5.08B
Total Debt	INR20.14B	INR30.89B	INR43.16B

	Dec 21	Sep 21	Jun 21
Revenue	INR54.79B	INR55.20B	INR55.04B
EBITDA	INR13.22B	INR12.86B	INR12.89B
Net Income	INR7.29B	INR7.11B	INR7.15B
Total Assets	INR	INR262.38B	INR
Total Cash	INR	INR5.29B	INR
Total Debt	INR	INR13.50B	INR

CIPLA Stock Price History

Cipla Limited Annual Stock Price History

Year	Open	Close	Change
2021	INR955.00	INR946.40	-0.90%
2021	INR822.80	INR955.00	16.07%
2020	INR479.95	INR822.80	71.43%

Cipla Limited Daily Stock Price History

Date	Open	High	Low	Close	Change	Volume
Jun 9, 2022	INR962.90	INR974.30	INR955.00	INR971.95	6.00%	1.41M
Jun 22, 2022	INR931.00	INR945.00	INR912.80	INR916.90	-3.96%	1.70M
Jun 13, 2022	INR955.00	INR984.75	INR947.80	INR954.75	-2.18%	3.02M

View More on "Price History" Section

(NSE:CIPLA) Stock Price FAQs

What is today's stock price of Cipla Limited (NSE:CIPLA)?

The current stock price of Cipla Limited (NSE:CIPLA) is INR946.40.
Today CIPLA stock price opened at INR948.00 after previous close of INR945.00.
During the day, Cipla Limited stock quote has varied from a low of INR938.80 to a high of INR959.00.

What is Cipla Limited's 52-week change?

CIPLA 52-week high stock quote is INR1083.00, which is 14.40% above the current share price.
The Cipla Limited (NSE:CIPLA) 52-week low stock price is INR785.91, which is 17.00% below the current share price.
Cipla Limited share price volatility (52-week beta) is 0.41.

Cipla Limited (NSE:CIPLA) FAQ

How Much is Cipla limited Worth?

Cipla limited's worth today based on market capitalisation is INR817.79B

How much dividend does Cipla limited Pay?

The current annualized dividend payout for CIPLA stock is INR5.00, the dividend yield is 0.49% and the payout ratio is 17.72%.
View More Details on Cipla limited's "Dividend" Section

What is Cipla limited’s Price to Earning (PE) ratio?

Cipla limited has a Price to Earning (P/E) ratio of 31.87. CIPLA stock also has a Price to Sales (P/S) ratio of 3.88.

What is the Cipla limited's ticker?

Cipla limited trades on the NSE stock market in India under the ticker symbol "CIPLA". Cipla limited’s stock symbol can also be displayed as "NSE:CIPLA".

Who are the owners of Cipla limited?

Cipla limited (NSE:CIPLA) is owned by 32.57% institutional shareholders and by 38.09% insiders. The rest is owned by the public.
Explore More Details on Cipla limited's “Ownership” Section

Who are the key executives of Cipla limited (CIPLA)?

Cipla limited's key executive team includes the following managers:

Mr. Umang Vohra, MD, Global CEO & Exec. Director (1971)
Ms. Samina Hamied, Exec. Vice-Chairperson (1976)
Dr. Raju Sunil Mistry M.A., Ph.D., Pres & Global Chief People Officer (1965)
Mr. Pradeep Bhadauria, Pres & Chief Scientific Officer (NA)
Mr. Kedar Upadhye CS, MBA, Global Chief Financial Officer (1977)
Ms. Geena V. Malhotra, Global Chief Technology Officer (NA)
Mr. Naveen Bansal, Head of Investor Relations (NA)
Mr. Gautam Rohidekar, Chief Legal Officer (NA)
Mr. Rajendra Kumar Chopra, Compliance Officer & Company Sec. (NA)
Ms. Heena Kanal, VP of Corp. Communications (NA)

What is Cipla limited’s Sector & Industry Classification?

Cipla limited (NSE:CIPLA) is classified under the "Healthcare" sector and under the "Drug Manufacturers-General" industry.

What is the ESG rating for Cipla limited (NSE:CIPLA) ?

ESG scores assess the degree to which a company’s enterprise business value is at risk driven by environmental, social, and governance issues. The scores are a measure of risk on an absolute scale of 0-100, with a lower score meaning less risk.

CIPLA’s total ESG score is 37.96. The company’s environmental score is 4.60, social score is 22.76 and governance score is 15.61.
Cipla limited (NSE:CIPLA) is involved in the following activities (which decreases its ESG score) : "animalTesting", "catholic".

How many employees work for Cipla limited?

Currently the number of employees working for Cipla limited is 25,672.

Where are Cipla limited's Headquarters?

Cipla limited (NSE:CIPLA) is headquartered in India.

What are Cipla limited's Address and Phone Number?

Cipla limited’s mailing address is Cipla House, Mumbai, India, 400013.
The company’s phone number is 91 22 2482 6000.

What is the official website for Cipla limited?

Cipla limited’s official website is http://www.cipla.com

Cipla Limited Stock (NSE:CIPLA)